SCHRODER INVESTMENT MANAGEMENT GROUP

Position in IRON — Disc Medicine, Inc.

CIK 1086619 London, X0

Position in IRON

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,656,999

+$398,681 QoQ

Shares Held

50,000

-1.9% QoQ

Ownership

0.130%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#73

of 216 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. IRON ranks #39 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	1,410,943	$99,683,122
2	VRTX	Vertex Pharmaceuticals Inc / Ma	169,270	$84,081,485
3	EXEL	Exelixis, Inc.	669,005	$36,400,560
4	INSM	INSMED Inc	298,372	$31,812,422
5	ALNY	Alnylam Pharmaceuticals, Inc.	95,194	$28,656,248
6	MDGL	Madrigal Pharmaceuticals, Inc.	51,630	$27,722,728
7	VERA	Vera Therapeutics, Inc.	510,787	$21,917,869
8	TVTX	Travere Therapeutics, Inc.	379,611	$21,565,700

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,656,999	50,000	-1.9%	Shares	Sole	2026-08-13
2026-03-31	$3,258,318	50,959	+1.7%	Shares	Sole	2026-05-14
2025-12-31	$3,978,678	50,103	-25.4%	Shares	Sole	2026-02-13
2025-09-30	$4,440,311	67,196	-18.5%	Shares	Sole	2025-11-13
2025-06-30	$4,366,604	82,451	-5.5%	Shares	Sole	2025-08-13
2025-03-31	$4,333,075	87,290	-4.6%	Shares	Sole	2025-05-13
2024-12-31	$5,800,466	91,490	-1.2%	Shares	Sole	2025-02-12
2024-09-30	$4,549,332	92,579	+0.5%	Shares	Sole	2024-11-13
2024-06-30	$4,152,704	92,139	+63.1%	Shares	Sole	2024-08-12
2024-03-31	$3,516,195	56,476	-3.1%	Shares	Sole	2024-05-14
2023-12-31	$3,365,097	58,260	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.